Literature DB >> 3618179

Intralaryngeal barriers to the spread of cancer.

J A Kirchner, D Carter.   

Abstract

Serial section studies were made of 412 surgical specimens removed by partial or total laryngectomy for laryngeal cancer. All sections were stained with hematoxylin and eosin. Selected sections were also stained for elastic tissue. Patterns of growth and spread of cancer within the larynx were found to be influenced by fibro-elastic ligaments and membranes which confined the tumor to anatomic compartments, and which provide margins of safety when performing partial laryngectomy.

Entities:  

Mesh:

Year:  1987        PMID: 3618179

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  18 in total

1.  Endoscopic supraglottic laryngectomy: a proposal for a classification by the working committee on nomenclature, European Laryngological Society.

Authors:  Marc Remacle; Anastasios Hantzakos; Hans Eckel; Anne-Sophie Evrard; Patrick J Bradley; Dominique Chevalier; Vojko Djukic; Marco de Vincentiis; Gerhard Friedrich; Jan Olofsson; Giorgio Peretti; Miquel Quer; Jochen Werner
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-08       Impact factor: 2.503

2.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

3.  Diagnosis of anterior commissure invasion in laryngeal cancer.

Authors:  Baris Naiboglu; Vefa Kinis; Sema Zer Toros; Tulay Erden Habesoglu; Ildem Deveci; Mehmet Surmeli; Erol Egeli
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-13       Impact factor: 2.503

4.  The periepiglottic space: topographic relations and histological organisation.

Authors:  M M Reidenbach
Journal:  J Anat       Date:  1996-02       Impact factor: 2.610

5.  Borders and topographic relationships of the paraglottic space.

Authors:  M M Reidenbach
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 6.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

7.  Cartilage invasion patterns in laryngeal cancer.

Authors:  Manuel Gómez Serrano; María Cruz Iglesias Moreno; Jesús Gimeno Hernández; Luis Ortega Medina; Cristina Martín Villares; Joaquín Poch Broto
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-06-23       Impact factor: 2.503

8.  The significance of pre-epiglottic space invasion in supraglottic laryngeal carcinomas.

Authors:  G Dursun; R Keser; T Aktürk; M N Akìner; A Demireller; S D Sak
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

Review 9.  Options for salvage after failed initial treatment of anterior vocal commissure squamous carcinoma.

Authors:  Patrick J Bradley; Alfio Ferlito; Carlos Suárez; Jochen A Werner; Eric M Genden; Ashok R Shaha; C René Leemans; Johannes A Langendijk; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-08-15       Impact factor: 2.503

10.  Has the degree of contrast enhancement with MR imaging in laryngeal carcinoma added value to anatomic parameters regarding prediction of response to radiation therapy?

Authors:  R Ljumanovic; P J W Pouwels; J A Langendijk; D L Knol; P van der Valk; C R Leemans; J A Castelijns
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.